Form 4 for MET MetLife
Accepted 2025-02-27 00:00:00 ET · period of report 2025-02-25 · accession 0001099219-25-000059 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-27 | 2025-02-25 | MET | DEBEL MARLENE | EVP, CRO | A - Grant | — | +41.2K | 121.3K | +51% | — |
| 2025-02-27 | 2025-02-25 | MET | DEBEL MARLENE | EVP, CRO | F - Tax | $82.20 | -12.7K | 137.0K | -8% | -$1.04M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-25 | A | A | 28,426 | — | 149,707 | D | — | — | (F2) Shares acquired from the determination of the performance factor for and payout of 2022-2024 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. |
| 2 | Common | Common Stock | 2025-02-25 | F | D | 12,706 | $82.20 | 137,001 | D | — | — | |
| 3 | Common | Common Stock | 2025-02-25 | A | A | 12,774 | — | 121,281 | D | — | — | (F1) Restricted stock unit award under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan. |